CIK 0001321834 · Non-accelerated filer<br>Smaller reporting company
Q/C TECHNOLOGIES, INC.
Sign in to watch- Ticker
- QCLS
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 856-848-8698
- Business address
- 1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
- Former names
- Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
- D Other Notice of Sales of Unregistered Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- NT 10-Q Other NT 10-Q
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- D Other Notice of Sales of Unregistered Securities
- 8-A12B Other Registration of Securities
- EFFECT Other Notice of Effectiveness
- D Other Notice of Sales of Unregistered Securities
- PRER14A Other PRER14A
- EFFECT Other Notice of Effectiveness
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- EFFECT Other Notice of Effectiveness
- D Other Notice of Sales of Unregistered Securities
- EFFECT Other Notice of Effectiveness
- DEFA14A Proxy Proxy Materials
- S-1MEF Other S-1MEF
Page 2 of 4 · 61 filings